HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Camilleri Selected Research

Dyspepsia (Indigestion)

1/2022Cannabidiol for Functional Dyspepsia With Normal Gastric Emptying: A Randomized Controlled Trial.
1/2020Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial.
1/2020Association between allelic variants in the glucagon-like peptide 1 and cholecystokinin receptor genes with gastric emptying and glucose tolerance.
1/2020Utility of the plasma pancreatic polypeptide response to modified sham feeding in diabetic gastroenteropathy and non-ulcer dyspepsia.
11/2019How does one choose the appropriate pharmacotherapy for pediatric patients with functional dyspepsia?
10/2019Relationship between symptoms during a gastric emptying study and intestinal chemosensitivity with daily symptoms.
1/2019Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.
1/2018Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia.
11/2017Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
6/2017Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Camilleri Research Topics

Disease

85Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
10/2022 - 03/2001
75Constipation
05/2022 - 10/2004
74Diarrhea
01/2022 - 08/2002
38Obesity
01/2022 - 12/2004
37Gastroparesis
11/2022 - 05/2006
28Pain (Aches)
01/2022 - 04/2003
22Weight Loss (Weight Reduction)
01/2022 - 10/2002
20Abdominal Pain (Pain, Abdominal)
01/2022 - 11/2007
19Dyspepsia (Indigestion)
01/2022 - 01/2005
17Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
11/2020 - 01/2005
16Nausea
11/2021 - 01/2003
15Inflammation (Inflammations)
01/2022 - 01/2002
14Opioid-Induced Constipation
01/2022 - 04/2011
14Type 2 Diabetes Mellitus (MODY)
01/2021 - 05/2007
10Vomiting
01/2019 - 04/2006
9Crohn Disease (Crohn's Disease)
01/2022 - 01/2002
9Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2021 - 06/2003
8Diabetes Mellitus
01/2021 - 05/2007
7Overweight
06/2016 - 12/2006
6Hypersensitivity (Allergy)
01/2022 - 09/2007
6Body Weight (Weight, Body)
01/2022 - 04/2008
5Celiac Disease (Celiac Sprue)
01/2022 - 12/2006
5Ileus
07/2019 - 06/2009
5Infections
08/2015 - 12/2005
4Neoplasms (Cancer)
01/2021 - 12/2004
4Eosinophilic Esophagitis
07/2015 - 12/2006
3Chronic Pain
01/2022 - 03/2011
3Visceral Pain
01/2022 - 10/2007
3Familial cyclic vomiting syndrome
01/2021 - 04/2006
3Liver Diseases (Liver Disease)
01/2021 - 08/2015
3Ulcer
01/2020 - 08/2015
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2018 - 01/2010
3Hyperglycemia
11/2018 - 09/2010

Drug/Important Bio-Agent (IBA)

59Bile Acids and Salts (Bile Acids)IBA
05/2022 - 03/2006
23Glucagon-Like Peptide 1 (GLP 1)IBA
12/2021 - 12/2006
20Opioid Analgesics (Opioids)IBA
01/2022 - 11/2007
15Pharmaceutical PreparationsIBA
01/2022 - 01/2002
15Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 03/2001
14Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2005
13elobixibatIBA
05/2022 - 10/2011
13Glucose (Dextrose)FDA LinkGeneric
05/2020 - 08/2003
11Hormones (Hormone)IBA
11/2020 - 12/2006
11GhrelinIBA
11/2020 - 10/2002
11prucaloprideIBA
12/2019 - 05/2008
9relamorelinIBA
01/2020 - 01/2013
7IncretinsIBA
05/2020 - 05/2007
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2006
6Antidepressive Agents (Antidepressants)IBA
01/2022 - 01/2005
6Proteins (Proteins, Gene)FDA Link
12/2021 - 07/2005
6LipidsIBA
11/2021 - 12/2014
6LiraglutideFDA Link
02/2021 - 06/2016
6AcidsIBA
10/2020 - 09/2007
6bile acid binding proteinsIBA
11/2019 - 10/2011
5Messenger RNA (mRNA)IBA
05/2022 - 12/2012
5Amitriptyline (Elavil)FDA LinkGeneric
01/2022 - 02/2013
5Phentermine (Adipex-P)FDA LinkGeneric
01/2022 - 03/2015
5Topiramate (Topamax)FDA LinkGeneric
01/2022 - 03/2015
5Analgesics (Analgesic Drugs)IBA
01/2022 - 05/2011
5CannabinoidsIBA
01/2022 - 08/2009
5AntralIBA
01/2022 - 04/2008
5Biological ProductsIBA
01/2021 - 01/2010
5Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
11/2020 - 04/2014
5linaclotideIBA
11/2019 - 09/2007
5LubiprostoneFDA Link
11/2019 - 05/2006
5Peptide YYIBA
10/2018 - 12/2006
4Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
05/2022 - 09/2012
4Colesevelam Hydrochloride (Welchol)FDA Link
12/2020 - 02/2010
4TaurineFDA Link
10/2020 - 01/2019
4Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
01/2020 - 08/2008
4Rifaximin (L 105)FDA Link
01/2020 - 12/2005
4EnzymesIBA
01/2020 - 07/2005
4Oligo-1,6-Glucosidase (Isomaltase)IBA
03/2019 - 06/2012
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2019 - 03/2015
4Glutens (Glutelin)IBA
01/2017 - 10/2004
4Chloride Channels (Chloride Channel)IBA
04/2011 - 05/2006
3Metoclopramide (Reglan)FDA LinkGeneric
01/2022 - 03/2015
3naldemedineIBA
01/2022 - 01/2021
3MucinsIBA
01/2022 - 03/2006
3Parasympatholytics (Antispasmodics)IBA
01/2022 - 01/2020
3Pregabalin (Lyrica)FDA Link
01/2022 - 08/2011
3Tight Junction ProteinsIBA
12/2021 - 11/2014
3AntiemeticsIBA
11/2021 - 01/2013
3Aprepitant (Emend)FDA Link
01/2021 - 11/2017
3AntidiarrhealsIBA
02/2020 - 02/2007
3Botulinum Toxins (Botulinum Toxin)IBA
01/2020 - 05/2006
3ramosetron (Nasea)IBA
01/2020 - 10/2010
3Opiate AlkaloidsIBA
01/2020 - 05/2011
3Neurotransmitter Agents (Neurotransmitter)IBA
01/2020 - 07/2007
3TD-5108IBA
11/2019 - 06/2010
3TabletsIBA
01/2019 - 08/2004
3goblet cell silencer inhibitorIBA
01/2019 - 11/2013
3ElectrolytesIBA
11/2018 - 01/2012

Therapy/Procedure

46Therapeutics
01/2022 - 01/2002
12Drug Therapy (Chemotherapy)
11/2019 - 05/2006
9Glycemic Control
01/2019 - 03/2009
6Bariatric Surgery
11/2020 - 03/2009
4Gluten-Free Diet
01/2020 - 10/2004
4Colectomy
01/2020 - 12/2004
3Analgesia
01/2022 - 04/2011
3Injections
01/2020 - 04/2008